Cargando…
A Protein Microarray-Based Investigation of Cerebrospinal Fluid Reveals Distinct Autoantibody Signature in Low and High-Grade Gliomas
Gliomas are one of the most aggressive primary brain tumors arising from neural progenitor cells. Delayed diagnosis, invasive biopsy, and diagnostic challenges stems the need for specific, minimally-invasive, and early diagnostic biomarkers. Tumor-associated (TA) autoantibodies are measurable in the...
Autores principales: | Gahoi, Nikita, Syed, Parvez, Choudhary, Saket, Epari, Sridhar, Moiyadi, Aliasgar, Varma, Santosh G., Gandhi, Mayuri N., Srivastava, Sanjeeva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784397/ https://www.ncbi.nlm.nih.gov/pubmed/33415070 http://dx.doi.org/10.3389/fonc.2020.543947 |
Ejemplares similares
-
Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays
por: Syed, Parvez, et al.
Publicado: (2015) -
Evaluation of autoantibody signatures in meningioma patients using human proteome arrays
por: Gupta, Shabarni, et al.
Publicado: (2017) -
Deep proteome investigation of high-grade gliomas reveals heterogeneity driving differential metabolism of 5-aminolevulinic acid
por: Ghantasala, Saicharan, et al.
Publicado: (2023) -
Quantitative Proteomic Analysis of Meningiomas for the Identification of Surrogate Protein Markers
por: Sharma, Samridhi, et al.
Publicado: (2014) -
Multiple Reaction Monitoring-Based Targeted Assays for the Validation of Protein Biomarkers in Brain Tumors
por: Ghantasala, Saicharan, et al.
Publicado: (2021)